AIR001 (sodium nitrite inhalation solution)

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	2

86. 肺動脈性肺高血圧症

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01725256 (ClinicalTrials.gov)	November 2012	8/11/2012	A Phase 2 Study to Determine the Safety and Efficacy of AIR001in Subjects With Pulmonary Arterial Hy ...	A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Dose Study to Determine the Safety and Eff ...	Pulmonary Arterial Hypertension	Drug: AIR001 (sodium nitrite inhalation solution)	Aires Pharmaceuticals, Inc.	NULL	Terminated	18 Years	75 Years	Both	29	Phase 2	United States;Australia;Hungary
2	NCT01409122 (ClinicalTrials.gov)	July 2011	1/8/2011	Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects	A Phase 1, Placebo Controlled, Blinded, Multiple Dose Escalation Study of AIR001 (Sodium Nitrite Inh ...	Pulmonary Hypertension;Pulmonary Arterial Hypertension	Drug: 15 mg sodium nitrite inhalationsolution;Drug: 90 mg sodium nitrite inhalationsolution;Drug: 45 ...	Aires Pharmaceuticals, Inc.	NULL	Completed	18 Years	56 Years	Both	42	Phase 1	United States

First Previous1Next Last